Fig. 2From: Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional studyThe positivity rates for the respective BHWSS items in the withdrawal symptom-positive population (n = 8)Back to article page